 |
Pricing
Turing Pharma: The Pre-Gouging Price
Why raise your public profile to a more loathsome level when you’re already dealing in the business of jacking up drug prices? If that’s your business strategy, why not do it quietly, cautiously, perhaps even slightly apologetically? Casey McDonald offers a different take on the Martin Shkreli drug-price-hiking business
...Read more |
 |
Pricing
Drug Price Controls: “Red Meat for the Left” or Russian Roulette?
Kaiser’s August healthcare poll results should put all on high alert given public sentiment and the rhetoric of the political season. Ed Schoonveld sounds the alarm and offers four initiatives to stall the surge towards government intercession on escalating prices
...Read more |
 |
Pricing
The Pathway to Public Rx Price Controls in 2016
The issue of drug price controls in public prescription programs has long been a point of contention. But today, writes Tom Norton, as several historical and contemporary factors continue to line up, we may be on a pathway to changing that. In fact, we may take major steps towards Rx price controls for all public drug programs as early as 2016
...Read more |
ZS 2015 AccessMonitorTM finds 53% of MDs “access-restricted” for sales reps.
 Read the report to learn what’s driving restrictions and what pharma can do. |
Regulatory
FDA Promotes Its Scientific Mission
In testifying before Congress last week on FDA regulation of long-awaited biosimilars, Janet Woodcock, director of the Center for Drug Evaluation and Research (CDER), emphasized the importance of ensuring that the evaluation of new therapies is based on sound science
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Regulatory
FDA Confirmation for Califf?
Last week, the White House nominated Robert Califf to head FDA. Califf has been on everyone’s short list to head the agency and was expected to replace commissioner Margaret Hamburg when she resigned in March 2015. Instead, FDA chief scientist Stephen Ostroff was appointed to hold the fort. But if President Obama wants progress on implementing personalized medicine, Califf will provide strong support, writes Jill Wechsler
...Read more |
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
 Contact your sales rep for more information and to secure your sponsorship. |
From Pharm Exec Magazine
Pharm Exec’s 14th Annual Industry Audit
If it was any other year, Pharm Exec’s 2014 Industry Audit results would be considered as a standout performance. But coming just on the heels of the industry’s spectacular revenue run up in 2013-2012, it dims a bit in comparison. But in a global business environment marked by collaborative, cross-sector relationships, it shows that biopharmaceuticals continue to lead other industries by outpacing the overall growth in the US economy
...Read more |
 |
 //BrainStorm Cell Therapeutics (Hackensack, NJ,.and Petach Tikvah, Israel) named Mr. Chaim Lebovits, who has been serving as the company's President since July 2007, as CEO. Mr. Lebovits succeeds Dr. Tony Fiorino, who will remain with the company in an executive scientific role.//Biota Pharmaceuticals (Atlanta, GA) appointed Armando Anido and Michael Dunne, M.D. to its Board of Directors.//TESARO (Waltham, MA) named Martin Huber, M.D., as Senior Vice President and Chief Medical Officer. //Anavex Life Sciences appointed Harald Hampel, MD, MA, PhD, MSc, to the its Scientific Advisory Board.//Martha A. Sanchez was appointed Chief Operating Officer of AlphaNet (Coral Gables, FL).// |
|
The Growing Aging Consumer Population - Living Longer, Living Smarter
LIVE WEBCAST: Monday, October 12, 2015 at 11 am EST
 Register for free
|
|
New tufts CSDD Research
Industry Adoption of eClinical Solutions and CDISC Standards
LIVE WEBCAST: Thursday, October 8, 2015 at 11:00 am ET
 Register for free
|
|
|
